Journal article
Amla therapy as a potential modulator of Alzheimer’s disease risk factors and physiological change
Journal of Alzheimer's disease : JAD, Vol.74(3), pp.713-733
2020
Abstract
There is currently no effective treatment for Alzheimer’s disease (AD), the most common form of dementia. It has been proposed, however, that a modest delay in onset can significantly reduce the number of cases. Thus, prevention and intervention strategies are currently the focus of much research. In the search for compounds that potentially confer benefit, the Amla fruit and its extracts have drawn attention. Amla preparations have been used for centuries in traditional Indian medicine systems such as Ayurveda, with various parts of the plant used to treat a variety of diseases. Here we review many animal-based studies, and some clinical trials, which have shown that Amla, and its extracts, exert many positive effects on dyslipidemia, hyperglycemia, inflammation, oxidative stress, apoptosis, and autophagy, that contribute to AD risk. Collectively, this evidence suggests that Amla may be of value as part of an effective disease-delaying treatment for AD.
Details
- Title
- Amla therapy as a potential modulator of Alzheimer’s disease risk factors and physiological change
- Authors/Creators
- E. Teimouri (Author/Creator)S.R. Rainey-Smith (Author/Creator)P. Bharadwaj (Author/Creator)G. Verdile (Author/Creator)R.N. Martins (Author/Creator)
- Publication Details
- Journal of Alzheimer's disease : JAD, Vol.74(3), pp.713-733
- Publisher
- IOS Press
- Identifiers
- 991005544896807891
- Copyright
- © 2020 IOS Press.
- Murdoch Affiliation
- Murdoch University
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
71 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.52 Neurodegenerative Diseases
- 1.52.57 Alzheimer's Mechanisms
- Web Of Science research areas
- Neurosciences
- ESI research areas
- Neuroscience & Behavior